Medical News

RSS

Science behind ME

Juliet Chenery-Robson decided to use photography to make people look at Myalgic Encephalopathy in a different light when her 18-year-old daughter Emilia was diagnosed with the illness five years ago.

29 Apr 2010

New MDC tool provides alternative choices to user's current prescription drugs

Healthcare reform legislation has enacted changes that will significantly affect the Medicare Part D prescription drug program. The most immediate impact of the reform aims to close the "donut hole", a component of the benefit design in which seniors must pay the full cost for their drugs themselves.

29 Apr 2010

Nanotechnology for study of individual molecule interaction in live cells

A University of Alberta-led research team has taken a major step forward in understanding how T cells are activated in the course of an immune response by combining nanotechnology and cell biology. T cells are the all important trigger that starts the human body's response to infection.

29 Apr 2010

RadNet reports financial guidance for fiscal year 2010

RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today reported financial guidance for the fiscal year ending December 31, 2010.

29 Apr 2010

Oncos Therapeutics completes $5.5M investment from HealthCap

Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a - 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding - 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.

29 Apr 2010

PAF annual report offers summary of issues impacting Americans' access to healthcare

Patient Advocate Foundation -- a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases -- today released their annual Patient Data Analysis Report, which documents the scope and complexity of the healthcare finance, access and job retention issues routinely confronted by patients at the national and state-specific level.

29 Apr 2010

Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that results from a pre-clinical study showed significant improvement in the delivery and half life of Å6, a proprietary peptide treatment for ovarian cancer currently in Phase 2 development by Angstrom Pharmaceuticals. Specifically, the incorporation of NexACT® enabled the dose of Å6 to be cut by half, or from twice per day to once per day delivered subcutaneously, while achieving the same level of efficacy in the mouse lung metastasis model.

29 Apr 2010

Masimo forms non-profit Foundation to improve patient safety, deliver advanced health care

Masimo Corporation, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the formation of The Masimo Foundation for Ethics, Innovation and Competition in Healthcare, a non-profit organization that will facilitate its corporate philanthropy.

29 Apr 2010

Genetic test to predict newborns requiring hospital readmission shortly after birth

The results of two separate research studies taking place at Children's Mercy Hospitals and Clinics will help physicians use genetic testing to prevent complications, and ease the worry of new parents by predicting in advance which newborns may require readmission to the hospital shortly after birth. The studies also will help physicians identify which of their young patients are likely to respond well - or not - to steroid therapy for asthma.

29 Apr 2010

OMT beneficial as adjunctive treatment in elderly people with pneumonia

A clinical trial of 406 subjects 50 years of age and older who were hospitalized with pneumonia showed a one-day reduction in the length of hospital stay in those patients who received osteopathic manipulative treatment (OMT) in addition to conventional medical care when compared to patients who received only conventional medical care. A per protocol analysis also showed a significant reduction in the duration of intravenous antibiotics and in respiratory failure or death in the group that received OMT when compare to the conventional care only group.

29 Apr 2010

Primary health care providers play key role in helping patients navigate Canadian health care system

For Canadians with chronic conditions, having a regular doctor doesn't necessarily mean they're receiving the safest or most supportive medical care. That doctor must also provide the basic elements of good primary care, two of which are: knowing their patient's history and helping to coordinate other aspects of their care, according to a Health Council of Canada bulletin released today.

29 Apr 2010

Removing unruptured AVM decreases risk of hemorrhaging, provides better outcomes to patients

Individuals diagnosed with a brain arteriovenous malformation, an abnormal tangle of arteries and veins, are at an increased risk of vessel rupture and bleeding that can cause stroke and permanent brain damage.

29 Apr 2010

Federal employee health program unlikely to extend young adult coverage on parents' plan this year

Kaiser Health News staff writer Jessica Marcy reports: "Many parents breathed a sigh of relief when they heard that health insurance companies were opening up coverage to young adult children.

29 Apr 2010

Gilead announces bioequivalence of Truvada in combination with Tibotec Pharmaceuticals' TMC278 NNRTI

Gilead Sciences, Inc. announced today it has obtained data supporting bioequivalence of a formulation of the fixed-dose combination of Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine hydrochloride, 25 mg).

29 Apr 2010

PMC Canada puts latest Canadian health research at fingertips of researchers

The flow of information and ideas amongst researchers is a fundamental element in turning knowledge into discoveries that will address the health challenges of tomorrow. Thanks to the newly launched PubMed Central Canada, Canadian researchers can now contribute to a growing, searchable digital archive of published Canadian health research.

29 Apr 2010

Americans' confidence in their ability to access and pay for healthcare declines

Americans' confidence in their ability to access and pay for healthcare continued to decline last month, according to a new consumer sentiment index from Thomson Reuters.

29 Apr 2010

Cardiac Science responds to FDA communications on AED recall

Cardiac Science Corporation, responded to FDA communications released yesterday related to the AED recall first announced in November, 2009. The Agency communication specifies additional affected models and offers further guidance to users of AEDs affected by potential component defects in some of the Company's AEDs.

29 Apr 2010

Uninsured medical expenses vie with retirement as most pressing financial concern for Americans

Uninsured medical expenses vie with retirement as the most pressing financial concern for Americans, according to a survey conducted for the American Institute of Certified Public Accountants by Harris Interactive.

29 Apr 2010

miacom diagnostics announces new tests for faster diagnosis of sepsis

"Conventional PCR tests (PCR is short for polymerase chain reaction, a highly sensitive method of detecting nucleic acids) require several hours to produce a result. lucesco Bacteremia IVD panels are not only much faster with a result after only 30 minutes, they are also much more cost-efficient.

29 Apr 2010

Emdat launches DaRT solution to help physicians utilize EMRs more efficiently

Emdat announces the launch of DaRT, or Discrete accurate Reportable Transcription, a solution that enables more efficient utilization of electronic medical records by seamlessly integrating with Emdat's online medical transcription platform.

29 Apr 2010

Medical News

Science behind ME

New MDC tool provides alternative choices to user's current prescription drugs

Nanotechnology for study of individual molecule interaction in live cells

RadNet reports financial guidance for fiscal year 2010

Oncos Therapeutics completes $5.5M investment from HealthCap

PAF annual report offers summary of issues impacting Americans' access to healthcare

Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

Masimo forms non-profit Foundation to improve patient safety, deliver advanced health care

Genetic test to predict newborns requiring hospital readmission shortly after birth

OMT beneficial as adjunctive treatment in elderly people with pneumonia

Primary health care providers play key role in helping patients navigate Canadian health care system

Removing unruptured AVM decreases risk of hemorrhaging, provides better outcomes to patients

Federal employee health program unlikely to extend young adult coverage on parents' plan this year

Gilead announces bioequivalence of Truvada in combination with Tibotec Pharmaceuticals' TMC278 NNRTI

PMC Canada puts latest Canadian health research at fingertips of researchers

Americans' confidence in their ability to access and pay for healthcare declines

Cardiac Science responds to FDA communications on AED recall

Uninsured medical expenses vie with retirement as most pressing financial concern for Americans

miacom diagnostics announces new tests for faster diagnosis of sepsis

Emdat launches DaRT solution to help physicians utilize EMRs more efficiently

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News